Hong-Jun Hao
Overview
Explore the profile of Hong-Jun Hao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao L, Zheng Y, Li F, Hao H, Gao F
World J Clin Cases
. 2023 Nov;
11(29):7101-7106.
PMID: 37946771
Background: Varicella-zoster virus (VZV) is a common viral infection, but meningitis is a rare complication of VZV infection. The cerebrospinal fluid glucose of viral meningitis is usually within the normal...
2.
Shao K, Yue Y, Zhao L, Hao H, Ding X, Jiang P, et al.
Clin Chim Acta
. 2022 Jun;
533:122-130.
PMID: 35750085
Objective: This study aims to establish an optimization procedure to define the cut-offs of quantitative assays for acetylcholine receptor antibody (AChRAb), evaluate their diagnostic performance in myasthenia gravis (MG), and...
3.
Lyu H, He X, Hao H, Lu W, Jin X, Zhao Y, et al.
World J Clin Cases
. 2021 Mar;
9(6):1359-1366.
PMID: 33644203
Background: Central nervous system graft--host disease (CNS-GVHD) is a rare cause of CNS disorders after allogeneic hematopoietic stem cell transplantation. Currently, establishing a diagnosis of CNS-GVHD is challenging because the...
4.
Han J, Yue Y, Gao X, Xie Y, Hao H, Li H, et al.
Front Neurol
. 2021 Feb;
12:604052.
PMID: 33633666
Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetylcholine receptors (AChR) or other functional molecules in the postsynaptic membrane at the neuromuscular junction. Vitamin D (VD)...
5.
Yue Y, Gao X, Tang T, Xie Y, Gu C, Hao H, et al.
J Neuroimmunol
. 2021 Feb;
353:577487.
PMID: 33578311
Complement component 3 (C3) had been proved to be involved in the pathogenesis and exacerbation of both myasthenia gravis (MG) patients and experimental autoimmune myasthenia gravis (EAMG) models. We evaluated...
6.
7.
Cai G, Gao Z, Yue Y, Xie Y, Gao X, Hao H, et al.
J Clin Neurosci
. 2019 Sep;
69:31-37.
PMID: 31473094
Abnormal CTLA-4 expression is involved in the development of myasthenia gravis (MG), and serum CTLA-4 levels are positively correlated with serum anti-AChR antibody concentration, which might be related with the...
8.
Jiang P, Yue Y, Hong Y, Xie Y, Gao X, Gu C, et al.
Front Neurol
. 2018 Jul;
9:529.
PMID: 30042722
Interleukin-4 (IL-4) is a potent growth and differentiation factor for B cells which play a vital role in the pathogenesis of myasthenia gravis (MG). IL-4 exerts its function by binding...
9.
Zhang X, Ding X, Wang Q, Yue Y, Xie Y, Hao H, et al.
J Clin Neurosci
. 2017 Mar;
40:180-184.
PMID: 28262400
Polymorphism in autoimmune regulator (AIRE) gene is associated with various autoimmune disorders. Abnormal AIRE expression is associated with the development of myasthenia gravis (MG). We investigated the association of polymorphism...
10.
Hong Y, Li H, Skeie G, Romi F, Hao H, Zhang X, et al.
J Neuroimmunol
. 2016 Sep;
298:51-7.
PMID: 27609275
Myasthenia gravis (MG) is an autoimmune disorder with heterogeneity. Antibodies against acetylcholine receptor (AChR), muscle-specific kinase (MuSK), titin and ryanodine receptor (RyR) were examined in 437 adult Chinese MG patients....